All three patients with NPR2 (p.R318W, p.I908T, p.R976H) gene mutations exhibited non-specific skeletal dysplasia and short stature, with good efficacy of recombinant human growth hormone (rhGH) treatment. This evidence concerns the gene NPR2 and skeletal dysplasia.